FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 8000

Substance profile for UNII Q662QK8M3B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
Q662QK8M3B
Preferred term
POLYETHYLENE GLYCOL 8000
Registry number
25322-68-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1307312
PubChem
0
NCIt
C84088
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1307312mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1307312
NCI ThesaurusC84088ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84088
FDA Substance Registration SystemQ662QK8M3Bprecision.fda.gov/uniisearch/srs/unii/Q662QK8M3B

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use ATORVASTATIN calcium tablets safely and effectively. See full prescribing information for ATORVASTATIN calcium tablets. ATORVASTATIN calcium tablets for oral administration Initial U.S. Approval: 19961
MIRTAZAPINE1
L-Methyl-MC Tablets3
AMOXICILLIN - amoxicillin tablet, film coated1
These highlights do not include all the information needed to use olanzapine tablets USP safely and effectively. See full prescribing information for olanzapine tablets USP. OLANZAPINE tablets USP for oral use. Initial U.S. Approval: 19965
These highlights do not include all the information needed to use olanzapine tablets USP safely and effectively. See full prescribing information for olanzapine tablets USP. OLANZAPINE tablets USP for oral use Initial U.S. Approval: 19961
These highlights do not include all the information needed to use atovaquone and proguanil hydrochloride tablets safely and effectively. See full prescribing information for atovaquone and proguanil hydrochloride tablets . ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS, for oral administration Initial U.S. Approval: 20001
Triamterene and Hydrochlorothiazide Tablets USP Revised: April 2012 Rx only1
Spironolactone Tablets, USP1
METFORMIN HYDROCHLORIDE tablet1
Spironolactone Tablets, USP2
Verapamil Hydrochloride Extended-Release Tablets, USP Rx Only1
Ferrous Sulfate Film Coated Tablets1
These highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19962
Citalopram Tablets, USP 10 mg, 20 mg, and 40 mg Rx Only1
Falessa Kit5
Imipramine Hydrochloride Tablets USP 10 mg, 25 mg and 50 mg1000
These highlights do not include all the information needed to use divalproex sodium extended-release tablets USP safely and effectively. See full prescribing information for divalproex sodium extended-release tablets USP. DIVALPROEX Sodium Extended-Release Tablets USP, for Oral Use Initial U.S. Approval: 20002
PENTOXIFYLLINE EXTENDED-RELEASE TABLETS, USP 400 mg1
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
These highlights do not include all the information needed to use Diovan safely and effectively. See full prescribing information for Diovan. Diovan (valsartan) Tablets Initial U.S. Approval: 19962
These highlights do not include all the information needed to use Fenofibrate Capsules, USP safely and effectively. See full prescribing information for Fenofibrate Capsules, USP. Fenofibrate Capsules, USP, for oral use Initial U.S. Approval: 19931
Spironolactone Tablets, USP2
Fluocinonide Cream USP, 0.05% Fluocinonide Cream USP, 0.05% (Emulsified Base) Fluocinonide Gel USP, 0.05% Fluocinonide Ointment USP, 0.05%2
These highlights do not include all the information needed to use olanzapine tablets USP safely and effectively. See full prescribing information for olanzapine tablets USP. OLANZAPINE tablets USP for oral use. Initial U.S. Approval: 19962
Nifedipine Extended-Release Tablets, USP For Oral Use Rx Only1
These highlights do not include all the information needed to use Valsartan safely and effectively. See full prescribing information for Valsartan. Valsartan Tablets, USP Initial U.S. Approval: 19964
These highlights do not include all the information needed to use quetiapine fumarate tablets safely and effectively. See full prescribing information for quetiapine fumarate tablets. QUETIAPINE fumarate tablets for oral use Initial U.S. Approval: 19972
PENTOXIFYLLINE EXTENDED-RELEASE TABLETS, USP 400 mg1
Nifedipine Extended-Release Tablets, USP4
These highlights do not include all the information needed to use ATORVASTATIN CALCIUM safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM. ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED for ORAL use. Initial U.S. Approval: 20123
Fluvoxamine Maleate Tablets These highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets. Fluvoxamine Maleate Tablets for oral administration Initial U.S. Approval: 19941
These highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19964
These highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
Mirtazapine Tablets, USP 15 mg, 30 mg and 45 mg Rx Only2
Atovaquone and Proguanil Hydrochloride Tablets1
CYCLOBENZAPRINE HYDROCHLORIDE TABLETS USP1
These highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19963
These highlights do not include all the information needed to use atorvastatin calcium tablets safely and effectively. See full prescribing information for atorvastatin calcium tablets. Atorvastatin Calcium Tablets for oral administration Initial U.S. Approval: 19961
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Amoxicillin and Clavulanate Potassium Tablets USP, Amoxicillin and Clavulanate Potassium for Oral Suspension USP, and Amoxicillin and Clavulanate Potassium Tablets USP (Chewable) safely and effectively. See full prescribing information for Amoxicillin and Clavulanate Potassium Tablets USP, Amoxicillin and Clavulanate Potassium for Oral Suspension USP, and Amoxicillin and Clavulanate Potassium Tablets USP1
These highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
Atovaquone and Proguanil Hydrochloride Tablets1
Nifedipine Extended-Release Tablets, USP For Oral Use Rx Only1
NIFEdipine Extended-Release Tablets, USP For Oral Use Rx Only1
These highlights do not include all the information needed to use Fluvastatin Sodium Extended-Release Tablets, USP safely and effectively. See full prescribing information for Fluvastatin Sodium Extended-Release Tablets, USP Fluvastatin Sodium Extended-Release Tablets, USP for oral use Initial U.S. Approval: 1993/ 20005
These highlights do not include all the information needed to use Lescol ® / Lescol ® XL safely and effectively. See full prescribing information for Lescol ® / Lescol ® XL. Lescol ® (fluvastatin sodium) capsules/ Lescol ® XL (fluvastatin sodium) extended-release tablets for oral use Initial U.S. Approval: 1993/ 20002
Imipramine Hydrochloride Tablets USP1
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19923
Triamterene and Hydrochlorothiazide Tablets USP Revised: April 2012 Rx only1
5dcd492f-cef1-41ba-b5d2-c79c31601f636
AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, 500 mg/125 mg and 875 mg/125 mg 2274 2275 Rx only1
Atovaquone and Proguanil Hydrochloride Tablets1
FLUOCINONIDE CREAM USP, 0.05% (Emulsified Base) FLUOCINONIDE CREAM USP, 0.05% FLUOCINONIDE GEL USP, 0.05% FLUOCINONIDE OINTMENT USP, 0.05% 0262 0263 0264 0265 FOR TOPICAL/EXTERNAL USE ONLY NOT FOR OPHTHALMIC USE Rx only1
AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, 500 mg/125 mg and 875 mg/125 mg 2274 2275 Rx only1
Atovaquone and Proguanil Hydrochloride Tablets1
These highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)2
These highlights do not include all the information needed to use Zolpidem Tartrate Tablets, USP safely and effectively. See full prescribing information for Zolpidem Tartrate Tablets, USP. Zolpidem Tartrate Tablets, USP - CIV Initial U.S. Approval: 19927
ATACAND HCT® 16-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32–25 candesartan cilexetil-hydrochlorothiazide2
Unknown Title1
These highlights do not include all the information needed to use Diovan safely and effectively. See full prescribing information for Diovan. Diovan (valsartan) Tablets Initial U.S. Approval: 19963
AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, 500 mg/125 mg and 875 mg/125 mg 2274 2275 Rx only1
be65d31a-87c1-4f37-a55d-7395bfe3642a2
ZOMIG ® (zolmitriptan) TABLETS ZOMIG-ZMT ® (zolmitriptan) ORALLY DISINTEGRATING TABLETS2
Calcium Acetate Tablets, USP2
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP Initial U.S. Approval: 19921
These highlights do not include all the information needed to use Diovan safely and effectively. See full prescribing information for Diovan. Diovan (valsartan) Tablets Initial U.S. Approval: 19961
These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets,5 mg and 10 mg Initial U.S. Approval: 19965
Amoxicillin Tablets, USP2
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets USP safely and effectively. See full prescribing information for metoprolol succinate extended release tablets USP. Metoprolol succinate extended-release tablets USP for Oral Use Initial U.S. Approval: 19923
These highlights do not include all the information needed to use Calcium Acetate Capsules safely and effectively. See full prescribing information for Calcium Acetate Capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 19907
0d466214-78a8-44cd-923c-c286a0f74f661
These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil hydrochloride tablets Initial U.S. Approval: 19961
These highlights do not include all the information needed to use donepezil hydrochloride (HCl) safely and effectively. See full prescribing information for donepezil HCl Tablets and donepezil HCl Orally Disintegrating Tablets (ODT) Donepezil HCl tablets Initial U.S. Approval: 19961
3e0cd209-220f-42a0-b13d-3ef13bdb6f7d4
Pravastatin Sodium1
These highlights do not include all the information needed to use ROZEREM safely and effectively. See full prescribing information for ROZEREM. ROZEREM (ramelteon) tablet, film coated for oral use Initial U.S. Approval: 20051
These highlights do not include all the information needed to use ARICEPT safely and effectively. See full prescribing information for ARICEPT Tablets and ARICEPT Orally Disintegrating Tablets (ODT). ARICEPT ® (donepezil hydrochloride) tablets Initial U.S. Approval: 19962
HYDROCODONE BITARTRATE AND IBUPROFEN TABLETS 7.5 mg/200 mg1
Fluocinonide Cream USP, 0.05% Fluocinonide Cream USP, 0.05% (Emulsified Base) Fluocinonide Gel USP, 0.05% Fluocinonide Ointment USP, 0.05%1
c095ffa5-3786-44ef-9a66-e8441e39dee11
NAPROXEN SODIUM TABLETS USP Rx only1
Triamterene and Hydrochlorothiazide Tablets USP Rx only1
983ce15f-cd37-4f3a-9e51-205860e809763
Gris-PEG ® (griseofulvin ultramicrosize) Tablets, USP 125 mg; 250 mg1
Calcium Acetate Capsules2
6b0e60bb-0e9a-45a7-8f92-a43d939f8deb3
ACTOPLUS MET® (pioglitazone hydrochloride and metformin hydrochloride) tablets2
7a51d289-2013-4d37-adf2-91ea49df79321
c83616c9-c222-4e3e-91bd-c7839406bb2a1
NAPROXEN SODIUM TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3882
ETODOLAC TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3618
DIOVAN (VALSARTAN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3594
DIOVAN (VALSARTAN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3593
HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3325
DIOVAN (VALSARTAN) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3218
ROZEREM TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3168
NAPROXEN SODIUM TABLET [BRYANT RANCH PREPACK]1001
ARICEPT (DONEPEZIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [BRYANT RANCH PREPACK]1000
ATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
ATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
ATORVASTATIN CALCIUM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
ATOVAQUONE AND PROGUANIL HCL (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
DIOVAN (VALSARTAN) TABLET [BRYANT RANCH PREPACK]1000
DIOVAN (VALSARTAN) TABLET [BRYANT RANCH PREPACK]1000
ETODOLAC TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
PENTOXIFYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
CALCIUM ACETATE (CALCIUM ACETATE) CAPSULE [REMEDYREPACK INC. ]79
RAPAMUNE (SIROLIMUS) SOLUTION RAPAMUNE (SIROLIMUS) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]47
FYCOMPA (PERAMPANEL) KIT FYCOMPA (PERAMPANEL) TABLET [EISAI INC.]25
ALTOPREV (LOVASTATIN) TABLET, EXTENDED RELEASE [SHIONOGI INC.]23
OSMOPREP (SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM PHOSPHATE, DIBASIC ANHYDROUS) TABLET [SALIX PHARMACEUTICALS, INC.]20
ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP]18
GABAPENTIN TABLET [TEVA PHARMACEUTICALS USA INC]18
GILDESS 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]18
NAPROSYN (NAPROXEN) TABLET EC-NAPROSYN (NAPROXEN) TABLET, DELAYED RELEASE NAPROSYN (NAPROXEN) SUSPENSION ANAPROX (NAPROXEN SODIUM) TABLET ANAPROX DS (NAPROXEN SODIUM) TABLET [GENENTECH, INC.]18
DEXILANT (DEXLANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]17
GILDESS 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]17
AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED AMOXICILLIN AND CLAVULANATE POTASSIUM POWDER, FOR SUSPENSION AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]16

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII Q662QK8M3B page 1 of 1 · 17 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683SOLUTIONOPHTHALMIC2 %w/w
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683CAPSULEORAL180 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683CAPSULE, EXTENDED RELEASEORAL98 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLETORAL1200 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, CHEWABLEORAL6.5 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, COATEDORAL0.21 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, DELAYED RELEASEORAL29 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, EXTENDED RELEASEORAL242 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, FILM COATEDORAL49 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, FILM COATED, EXTENDED RELEASEORAL14 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, ORALLY DISINTEGRATINGORAL1 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL8 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683SUPPOSITORYRECTAL208 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683FILMSUBLINGUAL24 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683CREAMTOPICAL361 mg
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683POWDERTOPICALNA
POLYETHYLENE GLYCOL 8000Q662QK8M3B25322683SOLUTIONTOPICALNA